SciELO - Scientific Electronic Library Online

 
vol.128 número1Uso de midodrín y congelación de semen en el tratamiento de las alteraciones del transporte espermático.: Caso clínicoPrevención y tratamiento de la obesidad desde la niñez: la estrategia para disminuir las enfermedades crónicas no transmisibles del adulto índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Revista médica de Chile

versión impresa ISSN 0034-9887

Resumen

CANO S, Antonio  y  BLUMEL M, Juan E. HERS study disturbs hormonal replacement therapy. Rev. méd. Chile [online]. 2000, vol.128, n.1, pp.98-104. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872000000100014.

Cardiovascular protection of hormonal replacement therapy was considered a fact. The effects of estrogens on lipid levels and vascular health gave biological support to estrogen cardioprotection. The recently published HERS study showing no protective effects of estrogen and progesterone replacement therapy on the risk of myocardial infarction or coronary deaths is provoking perplexity. These surprising results may have several causes such as the use of progesterone, the associated use of cardioprotective agents or the short observation period. However, the study results scope is rectricted to secondary prevention. These cannot be extrapolated to frequent conditions of postmenopausal women such as primary prevention or sequential schemes. Likewise, this investigation underscores the importance of a critical and continued evaluation of apparently well established therapeutic approaches. (Rev Méd Chile 2000; 128: 98-104)

Palabras clave : Cardiovascular diseases; Estrogen replacement therapy; Hormone replacement therapy; post-menopausal.

        · texto en Español

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons